(Q57012545)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10494482%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

title

Screening for activated protein C resistance before oral contraceptive treatment: a pilot study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10494482%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference

activated protein C resistance

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10494482%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

author name string

G Palareti

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10494482%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

M Frascaro

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10494482%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

C Flamigni

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10494482%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

L Gammi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10494482%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

G Gola

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10494482%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

G Fuschini

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10494482%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

S Coccheri

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10494482%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

language of work or name

English

0 references

publication date

1 May 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10494482%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10494482%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

volume

59

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10494482%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10494482%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

page(s)

293-299

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10494482%20AND%20SRC:MED&resulttype=core&format=json

Oral contraceptives and venous thromboembolism: a quantitative discussion of the uncertainties

31 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2899%2900033-5

A reevaluation of the risk for venous thromboembolism with the use of oral contraceptives and hormone replacement therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2899%2900033-5

Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2899%2900033-5

Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2899%2900033-5

Resistance to activated protein C as a basis for venous thromboembolism associated with pregnancy and oral contraceptives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2899%2900033-5

Factor V Leiden: should we screen oral contraceptive users and pregnant women?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2899%2900033-5

Thromboembolic disease developing during oral contraceptive therapy in young females with antiphospholipid antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2899%2900033-5

World distribution of factor V Leiden

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2899%2900033-5

Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2899%2900033-5

Activated protein C resistance: a comparison between two clotting assays and their relationship to the presence of the factor V Leiden mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2899%2900033-5

Thromboembolism and the combined oral contraceptive

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2899%2900033-5

Activated protein C resistance assay when applied in the general population.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2899%2900033-5

Resistance to activated protein C as a basis for venous thrombosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2899%2900033-5

Third generation oral contraception and venous thromboembolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2899%2900033-5

The role of drugs, particularly oral contraceptives, in triggering thrombosis in congenital defects of coagulation inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2899%2900033-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0010-7824(99)00033-5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10494482%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference